DruSO-CU

This international project aims to calculate the drug survival of omalizumab in a large multicenter daily practice cohort of patients with CU treated in UCARE centers, and identify determinants of drug survival in this overall international population differentiated by reason of discontinuation.

Contact: H.Rockmann@umcutrecht.nl

News

Are you familiar with Angioedema Centers of Reference and Excellence (ACARE)? In this episode, our host is joined by Dr Anete Grumach, to celebrate the recent successes of the ACARE network and discuss the future of this exciting initiative.

Link: www.medthority.com/csu-learning-zone/podcast-series/

Perhaps you have already heard about our Journal Club. Perhaps you also are or know a junior physician / PhD student who is interested in participating in the journal club. If so, please read on, and pass the information on

In this episode, our host is joined by Dr Caroline Mann, a urticariologist and sleep expert, who highlights the profound impact of sleep disturbance on quality of life in patients with urticaria and explains what can be done to address this common, but often overlooked aspect of the disease.

Link: https://www.medthority.com/csu-learning-zone/podcast-series/

Contact us

GA²LEN coordinating Office
c/o DGAKI
Robert-Koch-Platz 7
10115 Berlin, Germany

UCARE office
Laura Schwenner

info(at)ga2len-ucare.com